mgablin 15mg (14 Tablet / Pack)
A selective voltage-gated calcium channel ligand used to treat peripheral neuropathic pain.
Mgablin 15mg Tablets contain Mirogabalin, a selective ligand for the alpha-2-delta subunit of voltage-gated calcium channels. It works by decreasing calcium influx into hyper-excited presynaptic neurons in the central nervous system, which suppresses the release of excitatory neurotransmitters to effectively manage chronic neuropathic pain.
Purpose
Used for the symptomatic relief and management of peripheral neuropathic pain, including diabetic neuropathy and postherpetic neuralgia.
Ingredients
Mirogabalin 15mg
Warnings
Requires careful dose modification in patients with moderate to severe renal impairment based on creatinine clearance.
Avoid abrupt discontinuation of therapy; gradually taper the dose over at least one week to minimize the risk of withdrawal symptoms.
May cause significant somnolence and dizziness; avoid driving or operating heavy machinery until your individual tolerance is established.
Monitor patients closely for emergence or worsening of depression, suicidal thoughts, or any unusual changes in mood or behavior.
Side Effects
Somnolence, generalized drowsiness, fatigue, or localized sedation.
Dizziness, gait disturbance, or minor loss of physical coordination.
Peripheral edema, localized fluid retention, or gradual weight gain.
Blurred vision, dry mouth, or mild gastrointestinal disturbances like nausea.
Storage Instructions
Store below 30°C in a dry place protected from direct heat, sunlight, and moisture.
| Status | Active |